Cell therapy for neurological disorders

SP Svendsen, CN Svendsen - Nature Medicine, 2024 - nature.com
Cell therapies for neurological disorders are entering the clinic and present unique
challenges and opportunities compared with conventional medicines. They have the …

History and perspective of stem cell research

A Bongso, M Richards - Best practice & research Clinical obstetrics & …, 2004 - Elsevier
Several types of stem cell have been discovered from germ cells, the embryo, fetus and
adult. Each of these has promised to revolutionize the future of regenerative medicine …

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

G Bertolini, L Roz, P Perego… - Proceedings of the …, 2009 - National Acad Sciences
The identification of lung tumor-initiating cells and associated markers may be useful for
optimization of therapeutic approaches and for predictive and prognostic information in lung …

Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors

H Wakimoto, S Kesari, CJ Farrell, WT Curry Jr, C Zaupa… - Cancer research, 2009 - AACR
Glioblastoma, the most malignant type of primary brain tumor, is one of the solid cancers
where cancer stem cells have been isolated, and studies have suggested resistance of …

Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells

DE Redmond Jr, KB Bjugstad… - Proceedings of the …, 2007 - National Acad Sciences
Stem cells have been widely assumed to be capable of replacing lost or damaged cells in a
number of diseases, including Parkinson's disease (PD), in which neurons of the substantia …

Mild hypoxia enhances proliferation and multipotency of human neural stem cells

G Santilli, G Lamorte, L Carlessi, D Ferrari… - PloS one, 2010 - journals.plos.org
Background Neural stem cells (NSCs) represent an optimal tool for studies and therapy of
neurodegenerative diseases. We recently established a v-myc immortalized human NSC …

Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture

Y Sun, S Pollard, L Conti, M Toselli, G Biella… - Molecular and Cellular …, 2008 - Elsevier
Stem cell lines that provide a renewable and scaleable supply of central nervous system cell
types would constitute an invaluable resource for basic and applied neurobiology. Here we …

The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway

D Rueda, B Navarro, A Martı́nez-Serrano… - Journal of Biological …, 2002 - ASBMB
Endocannabinoids are neuromodulators that act as retrograde synaptic messengers
inhibiting the release of different neurotransmitters in cerebral areas such as hippocampus …

Non‐psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

J Palazuelos, T Aguado, A Egia… - The FASEB …, 2006 - Wiley Online Library
Cannabinoids, the active components of marijuana and their endogenous counterparts, act
on the brain and many other organs through the widely expressed CB1 cannabinoid …

Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model

HJ Lee, KS Kim, EJ Kim, HB Choi, KH Lee, IH Park… - Stem …, 2007 - academic.oup.com
We have generated stable, immortalized cell lines of human NSCs from primary human fetal
telencephalon cultures via a retroviral vector encoding v-myc. HB1. F3, one of the human …